Clinical Trials Directory

Trials / Conditions / Complicated Intra-abdominal Infections

Complicated Intra-abdominal Infections

12 registered clinical trials studyying Complicated Intra-abdominal Infections.

StatusTrialSponsorPhase
TerminatedReal-World Study of Ceftazidime Avibactam in China
NCT05487586
Pfizer—
CompletedCeftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-
NCT03830333
Merck Sharp & Dohme LLCPhase 3
UnknownItalian Register for the Study of Complicated Intra-Abdominal Infections
NCT03678298
World Society of Emergency Surgery—
CompletedEfficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
NCT02784704
Tetraphase Pharmaceuticals, IncPhase 3
CompletedEvaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to
NCT02475733
PfizerPhase 2
CompletedAntibiotic Safety (SCAMP)
NCT01994993
Michael Cohen-WolkowiezPhase 2 / Phase 3
CompletedEfficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
NCT01844856
Tetraphase Pharmaceuticals, IncPhase 3
CompletedStudy Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
NCT01072539
Pfizer—
CompletedProspective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Tr
NCT00752219
PfizerPhase 2
CompletedPost-Marketing Study Of The Safety Of Tygacil (Tigecycline)
NCT00683332
Pfizer—
UnknownAntibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587
University Hospital, Linkoeping—
CompletedErtapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-
NCT00389987
Merck Sharp & Dohme LLCPhase 3